Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:03 AM EDT
332.90quote price arrow down-6.67 (-1.96%)
Volume
4,054
Close
339.57quote price arrow up+6.56 (+1.97%)
Volume
5,400,655
52 week range
65.49 - 497.49
Loading...
  • Open337.21
  • Day High341.52
  • Day Low333.40
  • Prev Close339.57
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low65.49
  • 52 Week Low Date10/28/20

Key Stats

  • Market Cap137.067B
  • Shares Out403.65M
  • 10 Day Average Volume10.94M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change225.04

KEY STATS

  • Open337.21
  • Day High341.52
  • Day Low333.40
  • Prev Close339.57
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low65.49
  • 52 Week Low Date10/28/20
  • Market Cap137.067B
  • Shares Out403.65M
  • 10 Day Average Volume10.94M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change225.04

RATIOS/PROFITABILITY

  • EPS (TTM)8.01
  • P/E (TTM)42.39
  • Fwd P/E (NTM)7.72
  • EBITDA (TTM)3.918B
  • ROE (TTM)72.43%
  • Revenue (TTM)7.02B
  • Gross Margin (TTM)84.20%
  • Net Margin (TTM)49.79%
  • Debt To Equity (MRQ)7.26%

EVENTS

  • Earnings Date11/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO2:5502:55
FDA authorizes Moderna, J&J Covid boosters as Pfizer posts new efficacy data

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
286.36+16.94+6.29%
ILMN
Illumina Inc
411.58-1.87-0.45%
REGN
Regeneron Pharmaceuticals Inc
569.37+6.66+1.18%
BIIB
Biogen Inc
270.21+3.64+1.37%
GRFS
Grifols SA
13.87+0.05+0.36%